Innate Pharma innate-pharma.com


Public list: Pharma Startups (6570) Cancer Therapeutics (1180)

Innate Pharma is a biopharmaceutical company developing drugs targeting innate immunity. The Company is developing three product platforms (gamma delta T cells, NK cells and TLR), each directly or indirectly validated in clinical oncology settings. Innate Pharma's drug candidates also have development potential in the treatment of infectious disease and chronic inflammation.

Innate Pharma is a biopharmaceutical company developing drugs targeting innate immunity. The Company is developing three product platforms (gamma delta T cells, NK cells and TLR), each directly or indirectly validated in clinical oncology settings. I...Show all

Company (IPO / Went public)

Phone: 33 (0)4 30 30 30 30

Fax:

117, Avenue de Luminy - BP 30191

Marseille, 13009
France

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Innate Pharma $50M Oct 23, 2018
Callisto Pharmaceuticals $27.2M Jan 18, 2013
Inhibitex $209.8M Aug 12, 2005
See all 44 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Innate Pharma Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 9 investors

Competitors

Company Status Description Investors
See all 44 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Cd73 blockade Oct 09, 2015 Sep 08, 2020 Patent
Methods for detecting tissue infiltrating nk cells Jul 04, 2016 Aug 11, 2020 Patent
Neutralization of inhibitory pathways in lymphocytes Sep 15, 2015 Jul 14, 2020 Patent
Combination of anti-kir and anti-ctla-4 antibodies to treat cancer Sep 13, 2017 Jun 23, 2020 Patent
Enzymatic conjugation of antibodies Sep 12, 2017 Jun 09, 2020 Patent
See all 101 patents